Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Plos One
|
December 5, 2019
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study
Helen Dolengevich-Segal, Alicia Gonzalez-Baeza, Jorge Valencia, et al.
International Journal of Antimicrobial Agents
|
April 29, 2026
Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trial
Ignacio Perez-Valero, Diana Corona Mata, María Jose Crussells Canales, et al.
Journal of Clinical Medicine
|
December 9, 2023
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study
Pablo Ryan, Helen Dolengevich-Segal, Luis Ramos-Ruperto, et al.
Biomedicines
|
November 27, 2021
Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients
Daniel Valle-Millares, Óscar Brochado-Kith, Luz Martín-Carbonero, et al.
The Lancet. HIV
|
June 9, 2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Pablo Ryan, José L Blanco, Mar Masia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Miquel Massons, Jordi Sarto, Núria Guillén, et al.
HIV Medicine
|
January 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort
Jesús Troya, Rafael Mican, María José Galindo, et al.
Journal of the International AIDS Society
|
April 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort
Jara Llenas-García, María Del Mar Arcos Rueda, Ruth Calderón Hernaiz, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Plos One
|
December 5, 2019
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study
Helen Dolengevich-Segal, Alicia Gonzalez-Baeza, Jorge Valencia, et al.
International Journal of Antimicrobial Agents
|
April 29, 2026
Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trial
Ignacio Perez-Valero, Diana Corona Mata, María Jose Crussells Canales, et al.
Journal of Clinical Medicine
|
December 9, 2023
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study
Pablo Ryan, Helen Dolengevich-Segal, Luis Ramos-Ruperto, et al.
Biomedicines
|
November 27, 2021
Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients
Daniel Valle-Millares, Óscar Brochado-Kith, Luz Martín-Carbonero, et al.
The Lancet. HIV
|
June 9, 2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Pablo Ryan, José L Blanco, Mar Masia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Miquel Massons, Jordi Sarto, Núria Guillén, et al.
HIV Medicine
|
January 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort
Jesús Troya, Rafael Mican, María José Galindo, et al.
Journal of the International AIDS Society
|
April 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort
Jara Llenas-García, María Del Mar Arcos Rueda, Ruth Calderón Hernaiz, et al.
Page
of 3